1. Home
  2. ONMD vs CPHI Comparison

ONMD vs CPHI Comparison

Compare ONMD & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$5.62

Market Cap

38.5M

Sector

N/A

ML Signal

N/A

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

N/A

Current Price

$0.65

Market Cap

32.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
CPHI
Founded
2006
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.5M
32.3M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
ONMD
CPHI
Price
$5.62
$0.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 331.7K
209.9K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
N/A
N/A
Revenue
$1,359,000.00
★ $4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 111.35
N/A
52 Week Low
$0.49
$0.38
52 Week High
$6.50
$19.19

Technical Indicators

Market Signals
Indicator
ONMD
CPHI
Relative Strength Index (RSI) 95.07 40.28
Support Level $0.69 $0.53
Resistance Level N/A $0.68
Average True Range (ATR) 0.59 0.06
MACD 0.59 0.01
Stochastic Oscillator 86.62 14.55

Price Performance

Historical Comparison
ONMD
CPHI

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: